Company Overview
GoHealth, Inc. operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company offers Medicare plans, including Medicare advantage, Medicare supplement, prescription drug plans, and special needs plans. It also operates a technology platform that leverages machine-learning algorithms of insurance purchasing behavior to reimagine the process of matching a health plan for a consumer's specific needs. In addition, the company offers partner marketing services. It sells its products through internal and external agencies, as well as its platform. GoHealth, Inc. was founded in 2001 and is headquartered in Chicago, Illinois.
Recent Developments
- Dec 2025 Revenue of $361.85M (-54.7% YoY); net profit $-257.13M.
- Trailing 12 Months Year-on-year growth — revenue -94.6%.
- 5-Year Trend Long-term compounding — revenue CAGR -16.9%, profit CAGR -24.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -16.95% |
| 1 Year: | -94.60% |
Compounded Profit Growth
| 5 Years: | -24.30% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +7.56% |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | - |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- RSI (14)44.58 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -16.9% CAGR over 5 years.
- Earnings shrank at -24.3% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Financial Services).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | GOCO GoHealth Inc R2K | 0.37 | -0.02 | $6.17M | 0.00% | -48.92% | - | -16.95% | -24.30% |
| 2 | JPM JPMorgan Chase & Co. SPX | 342.89 | 16.42 | $918.78B | 1.87% | - | 16.47% | 5.35% | 7.56% |
| 3 | BRK-B Berkshire Hathaway Inc. SPX | 491.09 | 14.61 | $686.70B | 0.00% | - | 10.50% | 4.18% | 9.44% |
| 4 | V Visa Inc. SPX | 356.02 | 31.01 | $590.89B | 0.83% | 37.15% | 60.35% | 14.33% | 13.04% |
| 5 | MA Mastercard Incorporated SPX | 538.02 | 31.10 | $471.86B | 0.71% | 60.19% | - | 12.29% | 19.21% |
| 6 | BAC Bank of America Corporation SPX | 60.62 | 15.04 | $430.20B | 2.00% | - | 10.64% | 6.00% | 3.49% |
| 7 | MS Morgan Stanley SPX | 227.67 | 20.62 | $359.10B | 1.87% | - | 16.39% | 3.76% | 9.66% |
| 8 | GS The Goldman Sachs Group, Inc. SPX | 1,140.00 | 20.83 | $336.31B | 1.69% | - | 14.55% | - | 2.21% |
| 9 | WFC Wells Fargo & Company SPX | 85.29 | 13.18 | $261.00B | 2.11% | - | 12.03% | 4.02% | 15.98% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 87.41M | 141.01M | 127.06M | 163.36M | 204.18M | 196.90M | 211.73M | 270.59M | 158.65M | 133.05M | 183.16M | 142.78M | 132.04M | 185.60M | 105.87M | 118.29M | - | 220.97M | 94.05M | 34.19M | 12.64M | 11.91M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 39.27M | 32.41M | 20.09M | 4.35M | 8.32M |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 181.70M | 61.64M | 14.09M | 8.29M | 3.60M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 174.32M | 107.94M | 95.84M | 40.56M | 38.39M |
| Operating Income | -77.32M | 5.83M | -14.41M | -197.80M | 1.41M | -19.00M | -48.71M | -25.31M | -101.04M | -59.14M | -5.75M | -53.02M | -37.98M | -4.03M | -40.61M | -42.67M | - | 7.38M | -46.30M | -81.75M | -32.27M | -34.79M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 33.75M | -73.20M | -262.62M | -31.59M | -34.33M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 15.95M | 16.95M | 24.76M | 29.66M | 30.79M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -8.68M | -116.34M | -314.40M | -61.66M | -65.42M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.10M | -353.00K | -486.00K | -3.60M | 712.00K |
| Net Income | -77.34M | -937.00K | -22.87M | -56.42M | -2.09M | -12.00M | -20.24M | -13.48M | -43.82M | -30.00M | -9.18M | -28.94M | -23.91M | -9.22M | -26.00M | 6.78M | - | -4.41M | -54.28M | -165.85M | -32.59M | -37.17M |
| Diluted EPS | - | - | - | -0.65 | -0.02 | -0.12 | -0.18 | -1.74 | -5.28 | -3.41 | -1.12 | -3.27 | -2.61 | -1.04 | -2.70 | 0.46 | 1.56 | -0.52 | -5.10 | -11.80 | - | -2.36 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2018 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 226.21M | 877.35M | - | 631.67M | 734.67M | 798.89M | 361.85M |
| Cost of Revenue | - | - | - | 187.67M | 158.96M | 130.61M | 96.13M |
| Gross Profit | - | - | - | 444.00M | 575.71M | 668.28M | 265.72M |
| Operating Expenses | - | - | - | 725.14M | 644.70M | 675.33M | 418.66M |
| Operating Income | 28.76M | -64.55M | - | -281.14M | -68.99M | -7.05M | -152.94M |
| EBITDA | - | - | - | -211.55M | 24.10M | 173.71M | -333.66M |
| Interest Expense | - | - | - | 57.07M | 69.47M | 72.87M | 87.32M |
| Pretax Income | - | - | - | -375.62M | -151.12M | -5.05M | -501.09M |
| Tax Provision | - | - | - | 764.00K | 154.00K | 2.27M | -3.33M |
| Net Income | 28.12M | -44.27M | - | -148.71M | -63.26M | -2.93M | -257.13M |
| Diluted EPS | - | -3.35 | - | -17.72 | -7.19 | -0.66 | -20.17 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | 1.60B | 2.11B | - | 1.66B | 1.50B | 1.49B | 987.38M |
| Current Assets | - | - | - | 414.56M | 476.44M | 400.41M | 285.79M |
| Cash & Equivalents | 12.28M | 144.23M | - | 16.46M | 90.81M | 40.92M | 32.90M |
| Inventory | - | - | - | - | - | - | - |
| Receivables | - | - | - | 340.50M | 336.46M | 324.85M | 239.72M |
| Total Liabilities | - | - | - | 1.07B | 1.04B | 1.03B | 992.70M |
| Current Liabilities | 113.06M | 127.37M | - | 265.45M | 370.01M | 338.05M | 141.50M |
| Long Term Debt | 288.23M | 396.40M | - | 504.81M | 422.70M | 447.87M | 636.74M |
| Total Debt | - | - | - | 557.42M | 543.05M | 527.97M | 672.59M |
| Total Equity | - | 380.42M | - | 318.06M | 280.32M | 294.80M | 94.76M |
| Shares Outstanding | - | - | - | 8.96M | 9.82M | 10.61M | 16.98M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2018 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 5.44M | -114.22M | - | 60.90M | 109.14M | -21.61M | -121.95M |
| Investing Cash Flow | -6.17M | -14.52M | - | -13.51M | -13.73M | 3.81M | -8.25M |
| Financing Cash Flow | 63.00K | 260.66M | - | -115.05M | -21.11M | -32.03M | 122.00M |
| Capital Expenditure | - | - | - | -13.51M | -13.73M | -13.73M | -8.25M |
| Free Cash Flow | - | - | - | 47.39M | 95.41M | -35.34M | -130.19M |
| Net Change in Cash | - | - | - | -67.66M | 74.30M | -49.83M | -8.20M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2018 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | 70.3% | 78.4% | 83.7% | 73.4% |
| Operating Margin % | 12.7% | -7.4% | - | -44.5% | -9.4% | -0.9% | -42.3% |
| Net Margin % | 12.4% | -5.0% | - | -23.5% | -8.6% | -0.4% | -71.1% |
| ROE % | - | -11.6% | - | -46.8% | -22.6% | -1.0% | -271.3% |
| ROCE % | - | -3.3% | - | -20.2% | -6.1% | -0.6% | -18.1% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Centerbridge Partners, L.P. | 25.05% | 4.18M | $1.27M |
| 2 | Public Sector Pension Investment Board | 10.07% | 1.68M | $512.53K |
| 3 | Redwood Capital Management, LLC | 5.54% | 924.24K | $281.89K |
| 4 | Cdc Financial, Inc. | 4.51% | 753.03K | $229.68K |
| 5 | Blackrock Inc. | 2.29% | 382.05K | $116.53K |
| 6 | Geode Capital Management, LLC | 1.42% | 236.87K | $72.25K |
| 7 | Vanguard Capital Management LLC | 1.12% | 186.76K | $56.96K |
| 8 | Corient Private Wealth LLC | 0.72% | 119.54K | $36.46K |
| 9 | State Street Corporation | 0.47% | 78.87K | $24.05K |
| 10 | Barclays Plc | 0.41% | 68.92K | $21.02K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for GOCO
GoHealth (NASDAQ: GOCO) faces Nasdaq delisting as Chapter 11 plan threatens common equity - Stock Titan
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxQTUcwTW42Z0ZKaFY1Z1JxNlp4OHZhSUtPZ2otMDRYMF83OC1uUDhmVkJkb2w5OHlYLVFrZkwtWlo2aUMwTzBjcUh3SGpfcWd0QnNlYzZhRnFOZ1pob3M3SThkVmhmVG1ldWVMUjRoeHRHM000RXRkWjgyQTJWcjBPRl9mM2VnUzJDQ1RWRn…
How The GoHealth (GOCO) Narrative Is Shifting After Target Reset And Nasdaq Compliance Risks - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxOQ2NXV2FGS0NwZFdJY1RzX0pnZDFWZ2p0ZklyaXRPb3hQcTB0dFJ1eFNiTGQ5eWt2bkhodktEdDJ1SFlfcXBEQ2Y0dXVseFhmYXpDYlZZb1JPOElpWUk5dklIVG1EN1NIenhodWdwVzU5WlFNOU1oQU0tQXhvNjhoTVFnR052bHQ2ODY2aj…
GoHealth Inc. (GOCO) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxPcHlWb2h4VHNTTHRHbU9JdmQtNlRCZ3hBeGhzbnN6bDZqeGZQYmU4SEhXeUtTNHp1TzBsQS1ERUg1ck8zeFFkLXpDTnpHOGozemVwd3hmdW5kX2gyX3VEY3gtS3cyZldXcGFuYjd3S1NweFFRTXNhYnBtckExQktuZmdqaWFIWWh5UFB2LX…
GoHealth Faces Nasdaq Delisting Amid Chapter 11 Restructuring - The Globe and Mail
<a href="https://news.google.com/rss/articles/CBMi4gFBVV95cUxQQkxOMVRNc051VVBGZGpjZ2ZNMEpMaGlLTktXQ3E0RlIwUTlFOHZuQmp1NWVRbWdsR1VmWkF0NGhrbE9pd3FBZkRXVmRxX2h1YmtBYXpRYVVOZW4zc3RTSmswbVlVNG5IeTBQVDdWUDU5ZjFZNkhZb0lCWGpid05VbjhnX0FsWkpMVlRKZ2…
Analysts Estimate GoHealth (GOCO) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQLWRLZW5XSEtjaDFoQWdvWUstc2RTdGQ5Z3RhdlQ5RF9LbU1YV2pJdXNYOEl5dkZnaVdkejhJNGoyZy0zS2JabWtXQ3lyWm5RZ1lUWVM1MGZwVHZsQkdVVGw1M09OYzB2ckIzN2hadk5JN3pGSzJYaEtpU1RpVEV6WlBrQzV5T2FjNDZneU…
GoHealth (NASDAQ: GOCO) Chapter 11 plan cancels most existing equity - Stock Titan
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxQckJNLXBmYVZ4c3NIRlc1a2tOSVZtVzYwRy15ZzhPczlMQnNiR1VPRDVYVGFVelJSMDMyUmQ3aGQzWmdETE9ON2hURGpMRF9pV1dCS2x6RlBiQVptUGp4YXI5Vkc1eTI0cXl0WWkyUkhHcGg0UXZ5WVEyR2dRR1JwZGlGRzNRLUh0M1FmOE…
GOCO — Frequently Asked Questions
What is the current share price of GoHealth Inc (GOCO)?
As of 2026-07-14 21:23 PDT, GoHealth Inc (GOCO) trades at $0.37 on NGM. Its 52-week range is $0.34 to $0.40.
What is the market capitalisation of GOCO?
GoHealth Inc (GOCO) has a market capitalisation of $6.17M on NGM.
What is the P/E ratio of GOCO?
GOCO trades at a trailing price-to-earnings (P/E) ratio of -0.02. The industry average P/E is 13.30. Its price-to-book (P/B) ratio is 2.33.
Is GOCO a good stock to buy?
This page provides a data-driven analysis of GoHealth Inc (GOCO), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.